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Abstract
Elevated blood pressure in mid-life contributes significantly to the risk of cardiovascular disease. 
However, patterns of blood pressure increase may differ among individuals and may result in 
differential risk. Our goal was to examine the contribution of longitudinal patterns of blood 
pressure change to incidence of heart failure, coronary heart disease, stroke and cardiovascular 
disease mortality.
Latent class growth models were used to identify patterns of change in blood pressure across 4 
clinical examinations (1987–1998) among 9,845 ARIC cohort participants (mean age: 53.7 (SD 
5.7) years). Patterns of change in systolic blood pressure included slowly and steeply increasing, a 
decreasing and a sustained elevated blood pressure. Changes in diastolic and mid blood pressure 
(½ systolic + ½ diastolic) were less pronounced. The association of blood pressure pattern group 
membership with incidence of clinical outcomes was examined in follow-up from the fourth 
clinical examination (1996–1998) through Dec 31, 2011 using Poisson regression models adjusted 
for demographic and metabolic characteristics, and hypertension medication use. A gradient of 
rates of all events was observed across the identified patterns. Associations were attenuated after 
adjustment for covariates.
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Cumulative systolic blood pressure load rather than the temporal pattern of change in systolic 
blood pressure itself, plays a role in determining the risk of cardiovascular disease, in particular of 
heart failure and cardiovascular disease mortality, independent of blood pressure level measured at 
one point in time.
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Background
The association of elevated systolic and diastolic blood pressure (BP) with cardiovascular 
events is well documented. Even below hypertensive levels, a 20 mmHg increase in systolic 
BP nearly doubles the overall risk of stroke and coronary heart disease mortality.1, 2 Most 
longitudinal population-based studies examining the association of BP with cardiovascular 
outcomes rely on BP measured at one point in time and are not able to account for changes 
in BP occurring in midlife.1–3 Extant research shows that BP increases in midlife for most 
individuals; however, the pattern of change may differ. 4–7 Three parameters: baseline BP 
levels, directionality, and rate of change characterize temporal patterns of change in BP. So 
far, few studies have examined the association of attributes of change in BP with 
cardiovascular disease (CVD).4–7 It has been suggested that in young adults, cumulative BP 
exposure may determine cardiovascular risk later in life.4, 8 However, it remains unclear 
whether it is the cumulative BP load itself or the temporal pattern of that accumulation that 
determines the risk. Thus, the objective of this study was to apply the longitudinal approach 
to the examination of the association of BP with clinical outcomes. We aimed to describe 
patterns of change in blood pressure over a 9-year period in a large biracial cohort of 
middle-aged men and women, and evaluated the association of those patterns with the 
incidence of coronary heart disease (CHD), heart failure (HF), stroke, and CVD mortality 
occurring during an extended follow-up.
Methods
Study population
The Atherosclerosis Risk in Communities (ARIC) Study was initiated in 1987 as a 
prospective cohort of 15,792 men and women, age 45–64 years, selected through probability 
sampling from four U.S. communities: Washington County, Maryland; Forsyth County, 
North Carolina; suburbs of Minneapolis, Minnesota; and Jackson, Mississippi. Standardized 
examinations and interviewer-administered questionnaires were conducted at baseline and at 
four follow-up examinations. 9 Included in the analyses were ARIC cohort participants with 
blood pressure measurements at the first four triennial visits (n=11,656) (Figure 1). 
Excluded were those with prevalent CHD, HF and stroke at visit 4 (n=1233), those with 
missing data on covariates included in the models (n=541), as well as those self-identifying 
as of non-white or non-black race (n=30), or as black at the Washington County, and 
Minneapolis field centers (n=36). The final sample included 9,852 participants.
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Sitting systolic and diastolic BP was measured three times at visits 1–3 and twice at visit 4 
using a random zero sphygmomanometer. The average of the second and third measurement 
(first and second at visit 4) was used in analyses. To account for use of antihypertensive 
medications, 10mm Hg was added to systolic and diastolic BP measurements. 10–12 Mid 
arterial BP, a combined measure of systolic and diastolic BP, was calculated as ½ systolic 
BP+ ½ diastolic BP. 13
Outcomes assessment
Outcomes of interest in this study, HF, stroke, CHD, and CVD mortality, were assessed as 
incident events during a median 13.2 years of follow-up from visit 4 through December 31, 
2011.
Hospitalized cardiovascular events were identified through active surveillance of medical 
records in study area hospitals and through participants’ self-report of prior hospitalizations 
provided during the annual telephone follow-up interview. Incident CHD was defined as 
incident myocardial infarction (MI). MI events were adjudicated by a panel of trained 
clinicians and identified as definite or probable MI which did not result in a death within 28 
days based on ICD-9 codes 410 and 411.0 and information obtained from ECG and 
laboratory findings available from participants’ medical records. Incident HF events were 
identified on the basis of the presence of ICD-9 code 428.xx in any position in the inpatient 
medical record. Incident stroke events were identified based on the presence of ICD-9 codes 
430–438 as well as presence of neurological signs and symptoms and adjudicated by a panel 
of clinicians as ischemic or hemorrhagic stroke. Due to small numbers, we did not 
differentiate between stroke subtypes. Cardiovascular deaths were identified using ICD-9 
codes (390–398, 401–404, 410–429, 430–434, 436–438, 440–448) for deaths occurring 
through the year 1999 and ICD-10 codes (I00–I78) thereafter.
Covariates
Covariates included in multivariable models were age; race; gender; ARIC Study field 
center; educational level (<=11 or >11 years of attained education), obtained via interviewer-
administered questionnaire at the baseline examination; HDL and LDL cholesterol measured 
at visit 4; 14 cigarette smoking status, defined as never or ever smoker at any of the 4 clinic 
visits; obesity, defined as body mass index (BMI) >30 kg/m2 at any of the 4 clinic visits; and 
diabetes defined as self reported history of a physicians diagnosis, use of diabetes 
medication, fasting blood glucose level of at least 126 mg/dL, or a nonfasting glucose level 
of at least 200 mg/dL reported during any of the 4 clinic visits.
Statistical analysis
Descriptive statistics are presented as means (SD) and percentages. Normally distributed 
continuous values were compared using a t-test. The chi square statistic was used to evaluate 
categorical values.
We used latent class growth models to identify participants with similar underlying patterns 
of change in systolic, diastolic and mid arterial BP over a 9-year period (from ARIC visit 1 
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to visit 4). The models were fit using STATA 13.1 “traj” program (equivalent to PROC 
TRAJ in SAS).15–18 Based on the Bayesian Information Criterion (BIC), we selected the 
number and shape of the trajectories that best represented distinct patterns of change. 16 
Model adequacy was assessed by comparing estimated with average posterior probabilities 
of group assignment, by estimating the odds of correct group classification, and examination 
of the 95% confidence intervals around the trajectories.16
We fit Poisson regression models to estimate the rates of all events in each identified pattern 
of systolic, diastolic and mid arterial BP change. Incidence rate ratios were calculated with 
pattern 1 (sustained low BP throughout) as referent. Beginning of follow-up was defined as 
date of visit 4. End of follow-up was defined as the date of an incident event, death, date of 
last known status or end of study period (December 31, 2011), whichever came first (Figure 
1).
Finally, we performed several sensitivity analyses. To partially account for the exclusion of 
participants with prevalent events occurring during the exposure period, we shortened the 
period during which we observed change in BP and modeled BP patterns of change from 
baseline to ARIC visit 3 (6-year period) in association with cardiovascular outcomes 
occurring the follow-up through December 31, 2011. We also stratified BP patterns by visit 
4 age group (<=64 years or >64 years), race, and sex. We also modeled patterns of BP 




Among 9,852 ARIC cohort participants eligible for this study, at ARIC visit 4 the average 
age was 62.6 years (SD 5.6), 41.4% of the participants were male, 21.4% Black, and 17.4% 
had less than high school education (Table 1). The average BP at visit 1 was 118 mmHg (SD 
16.8) for systolic, and 75 mmHg (SD 12.0) for diastolic BP. By visit 4 the average systolic 
BP increased to 127 mmHg (SD 18.8), diastolic BP decreased slightly to 74 mmHg (SD 
11.7). Over the course of 9 years, from the baseline visit 1 to visit 4, 50.9% of participants 
reported being ever smokers, 50.4% had ever been diagnosed with hypertension and 18.2% 
with diabetes, while 39.0% had a BMI >30 kg/m2 during at least one of the four ARIC 
visits.
Patterns of change in systolic BP
We identified six distinct patterns of change in systolic BP over the 9-year period (Figure 2). 
Three patterns (patterns 1–3) were characterized by a slow sustained increase from different 
baseline systolic BP levels, with the means remaining below the 140 mmHg threshold 
throughout the exposure period. Majority of study participants (84.2%) fell into one of those 
three patterns. The average increase in systolic BP over the 9-year period for patterns 1, 2, 
and 3 was 5.9 mmHg, 9.1 mmHg, and 11.3 mmHg respectively. A steep increase in systolic 
BP from just under 140 mmHg to 170 mmHg (average 33.8 mm Hg) over the 9-year period 
(pattern 4) was observed for 6.0% of participants. Participants in the fifth group (pattern 5, 
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7.2% of study participants) experienced a slight decrease in systolic BP (average 4.0 
mmHg), but their average systolic BP remained above the 140 mmHg threshold throughout. 
Only 2.1% of study participants were classified into the pattern with average systolic BP 
elevated at above 160 mmHg throughout the period from visit 1 to visit 4 (pattern 6). 
Participants in this group showed an average increase in BP of 9.4 mmHg over the 9-year 
period.
We observed a differential distribution of demographic and metabolic risk factors across the 
patterns of change in SBP. Those with high levels of systolic BP throughout (systolic BP 
patterns 4–6) were older than those with patterns of systolic BP consistently below 140 
mmHg. Across the six distinct patterns of change in systolic BP (patterns 1 through 6) we 
observed gradients in the proportion of Blacks (from 9.9% to 41.6%), proportion of 
participants with BMI>30 kg/m2 at any of the 4 visits (from 19.8% to 50.2%) as well as 
proportion of those with diabetes (from 6.5% to 35.4%). Use of antihypertensive 
medications was the highest among participants with BP consistently above 140 mmHg 
(77.3%–92.3%).
In sensitivity analyses, we observed that the shape and number of patterns of systolic BP 
change did not differ by race or age group. The number of patterns differed slightly by 
gender, however the overall patterns of systolic BP change and the distribution of 
participants across those patterns were similar. We identified three distinct patterns of 
change in diastolic BP, which differed by baseline levels and suggested no significant change 
over the 9 years of observation (see appendix).
We observed less variability in mid arterial BP patterns change as compared to patterns of 
change in systolic BP patterns. We attributed this to the relatively minor change that was 
observed in diastolic BP over the 9-year period (supplemental Figures S1 and S2).
Incidence rates
Although estimates of the rates of CVD events across distinct patterns of change were 
examined for systolic, diastolic, and mid arterial BP, we focus on incidence of CVD across 
patterns of change in systolic BP. Systolic BP is more predictive than diastolic BP of future 
CVD events and in older age groups, such as that of the ARIC cohort, age-related changes in 
diastolic BP are less prominent than those observed for systolic BP. 2, 19, 20 Mid arterial BP, 
although associated with long-term outcomes,21 is not used in clinical settings and, as a 
composite measure of systolic and diastolic BP, it is less reflective of the underlying 
physiology.
Sequential models estimating rates of CVD incidence across patterns of change in systolic 
BP were built from an initial model adjusting for baseline age (model 1), to a model that 
included additional demographic characteristics and comorbidities (model 2), and lastly to a 
model that also included systolic BP measured at visit 4 (model 3). In age-adjusted models 
(model 1) we observed steep gradients of the incidence of CHD, HF, stroke, and CVD 
mortality across systolic BP patterns 1–4 (Table 2, Figure 3). Those gradients were less 
pronounced in the models that accounted for demographic characteristics and comorbidities 
(model 2) and were further attenuated after accounting for systolic BP at visit 4 (model 3) 
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for all outcomes, with the exception of CVD mortality. We found no significant difference in 
the incidence of CHD, HF, and stroke between patterns 4 through 6. The incidence rate for 
CVD mortality was highest among study participants in pattern 6 systolic BP, as compared 
to all other patterns.
We examined selected contrasts of systolic BP patterns in order to separate the effect of 
temporal change in BP from the effect of the level of BP measured at one point in time on 
the risk of CVD outcomes. We first compared those who had similar systolic BP at visit 4 
(mean systolic BP 141.7 mmHg (SD 11.8)), but who arrived at that BP either as a result of a 
gradual increase from the initial mean 129.1 mmHg (SD 10.7) (pattern 3) or through a 
decrease from the initial mean 151.1 mmHg (SD 12.4) systolic BP (pattern 5). We observed 
that age-adjusted rates of all events were higher in participants whose systolic BP was 
decreasing during the exposure period as compared to those with a gradual increase in 
systolic BP, although that difference was attenuated for CHD and stroke (and less so for HF 
and CVD death) after accounting for systolic BP at visit 4, demographic characteristics and 
comorbidities.
In the second contrast we compared those whose systolic BP increased steeply from pre-
hypertensive levels to above 140 mmHg (pattern 4) with those whose systolic BP remained 
above 140 mmHg throughout the exposure period (pattern 6). For these two group with a 
mean visit 4 systolic BP of 170 mmHg, we observed no difference in rates for CHD, HF, and 
stroke. However, CVD mortality rates were lower among the group with shorter exposure to 
systolic BP levels of ≥140 mmHg (pattern 4).
To examine the effect of cumulative systolic BP exposure, we compared patterns with 
similar cumulative systolic BP load but with opposite direction of systolic BP change 
(patterns 4 and 5). We found that among the two groups the rates for all events were similar 
despite different temporal patterns and different systolic BP levels at baseline and at visit 4.
The trend in the age adjusted incidence rates of all events across patterns of mid arterial BP 
was similar to the trend observed across systolic BP patterns, however after adjusting for 
demographic characteristics and other risk factors the trend remained for HF and CHD 
although it was much attenuated (Table S2).
In a sensitivity analysis in which we modeled the patterns of change in systolic BP from 
baseline to ARIC visit 3 (a 6-year period), we identified 6 patterns that were very similar to 
the patterns identified in the main analysis. Associations with outcomes were similar to 
those observed for trajectories accumulated over a 9-year period (data not shown).
Incidence rate ratios
In age-adjusted models (model 1) we observed a gradient in incidence rate ratios (IRR) of 
CVD events across systolic BP patterns 2 through 4 relative to pattern 1. This gradient was 
less pronounced after adjustment for other covariates (model 2) and further attenuated after 
accounting for systolic BP at visit 4 (model 3). Participants for whom change in systolic BP 
followed patterns 4 through 6 experienced similar relative rates of CHD, HF, and stroke 
relative to pattern 1 in all models (Figure S3).
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In this study of middle-aged men and women we identified 6 patterns of change in systolic 
BP, 3 patterns of change in diastolic BP, and 5 patterns of change in mid arterial BP 
occurring over the course of 9 years. The majority of participants experienced a slow 
increase in systolic BP, however, this increase was not accompanied by similar changes in 
diastolic BP. Average diastolic BP remained stable or slightly decreased over time for most 
participants. Consequently, we observed low variability in mid arterial BP, which combined 
the systolic and diastolic BP measurements. These temporal changes were consistent with 
previous findings of Willis et al who observed a gentle underlying increase in midlife 
systolic BP for the majority of the study population.6, 7 Temporal systolic BP patterns of 
change were associated with different incident rates of HF, CHD, stroke, and CVD mortality 
in the age adjusted models, however those differences were attenuated after adjustment for 
demographic characteristics and comorbidities. Our findings suggest that it is the cumulative 
load of BP during midlife as opposed to the temporal pattern of that accumulation, that plays 
a role in determining the risk of cardiovascular events, in particular of HF and CVD 
mortality.
Demographic and metabolic characteristics varied significantly by pattern of change in 
systolic BP, and a strong gradient in those characteristics across the patterns of systolic BP 
was observed (Table 1). That gradient was reflected in rates of incidence of CVD events in 
age-adjusted models (model 1). However, after accounting for participants’ characteristics, 
the gradient was less pronounced. The associations were significant for parallel patterns of 
gradual increase in BP in the lower range of BP. This finding is in accordance with extant 
studies, which suggest that any increase in systolic BP independent of baseline is associated 
with increased CVD risk. 1, 2 Further, results of our study suggest that a reduction in systolic 
BP may not fully reverse the effect of sustained hypertension earlier in life which may be 
due to physiological changes in the vasculature, such as arterial stiffening, fibrosis, and 
calcification. 22
To this day, estimates of the association of patterns of change in systolic BP with outcomes 
are sparse. In a recent study of BP trajectories, Allen et al. identified 5 distinct patterns of 
change in mid BP among young adults over a 25-year period and found that individuals with 
elevated mid BP and those with increasing mid BP over time were at a greater risk of 
subclinical disease (measured by coronary artery calcification), concluding that the temporal 
change is predictive of risk independent of BP measured at one point in time. 4 In another 
study Wills et al. observed that among middle-aged adults a marked increase in systolic BP 
as compared to a gradual increase is associated with an increase in the risk of angina. 6, 7 
Our study contributes to the existing literature by examining associations with clinical 
outcomes and comparing cumulative systolic BP load to the patterns of this accumulation 
(similar cumulative load but opposite direction of longitudinal change).
Strengths and limitations
The strengths of our study include a large community-based population and availability of 
four measurements over a 9-year period. All BP measurements were taken by trained staff 
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according to standardized ARIC protocols and repeatability of measurements was high. In 
addition, information was available on many demographic and metabolic characteristics at 
all ARIC visits and through annual follow up. All events were identified over a long follow-
up and were adjudicated by physicians and trained reviewers.
Despite these strengths, we note some limitations of our study that should be taken into 
consideration. For our estimates of change in BP we relied in on four measurements over a 
9-year period which may not have captured more frequent fluctuations in BP. Hypertension 
medication use may not reflect adherence to medication. To account for medication use we 
added 10 mmHg to the existent measurements of BP, which may not accurately represent the 
actual response to medication by some individuals. Due to a high proportion of individuals 
reporting anti-hypertensive medication use, we could not stratify analyses by medication use 
status. In a sensitivity analysis we included hypertension medication use as an independent 
variable in our models. This did not change our results. BP patterns obtained through the 
statistical procedure “traj/proc traj” are dependent on the user-specified parameters of 
number and shape of trajectories during modeling. To address this limitation, we adhered to 
established criteria for model specification examining the BIC, average posterior 
probabilities of group assignment, and odds of correct classification (OCC). In our final 
model the average posterior probabilities ranged from 0.79–0.90 (expected to be >0.7) and 
OCC ranged from 5.6–434.5 (expected to be >5). It is also worth noting that grouping 
patterns of change in BP may have obscured some of the individual variability in temporal 
changes in BP and may have resulted in attenuated estimates. In our sensitivity analysis we 
addressed the issue of attrition by modeling patterns of change in systolic BP over a 6-year 
period (ARIC visit 1 through visit 3) and including in our analyses incident events 
happening between visit 3 and visit 4. A small number of group members and events with 
patterns of systolic BP consistently above the 140 mmHg level resulted in wide confidence 
intervals and we were unable to detect significant differences in estimates. Similarly, we 
were unable to conduct analyses stratified by race and gender due to the small number of 
events in each stratum-pattern group.
Perspectives
In this large population-based study of middle-aged adults, we observed that distinct patterns 
of change in systolic blood pressure over a period of 9 years differentially influenced the risk 
of CVD events. However, our results suggest that the cumulative systolic BP load rather than 
the temporal pattern of change in systolic BP itself plays a role in determining the risk of 
CVD, independent of BP level measured at one point in time. Our results support previous 
findings of observational studies, which suggest that any increase in systolic BP is 
detrimental to health. Our results are also in line with the most recent findings from the 
clinical trial on BP control,23 which suggest that intensive treatment of elevated BP to below 
the guideline recommended levels results in lower rates of fatal and non-fatal CVD. In 
addition, we observed that exposure to elevated systolic BP at any point in midlife results in 
higher rates of cardiovascular events even if systolic BP is lowered later in life.
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Results of this study strongly underscore the importance of maintaining blood pressure 
below the guideline recommended levels throughout the life course.24, 25 Our results also 
support clinical efforts aimed at preventing any increase in systolic blood pressure, 
independent of its absolute value.
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Refer to Web version on PubMed Central for supplementary material.
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This study describes longitudinal patterns of change in BP over 9 years in a large biracial 
cohort of men and women and evaluates the association of those patterns with clinical 
outcomes.
Results of this study suggest that the cumulative load of BP, rather than the longitudinal 
change itself, determines the risk of CVD events.
What is relevant?
Our results support the findings from previous cohort studies and clinical trials, and 
implement a life course approach to studying the association of BP with clinical 
outcomes.
Summary
Results of this study underscore the importance of primary prevention of hypertension as 
well as the importance of maintaining a BP below the guideline recommended levels 
throughout the life course.
Petruski-Ivleva et al. Page 11














Timeline of exposure and follow-up assessment.
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Figure 2. Patterns of change in systolic BP over the 9-year period among ARIC study 
participants
Confidence intervals represented by dashed lines.
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Figure 3. Incidence rates per 10,000 person-years by systolic BP pattern
Model 1: adjustment for age at visit 4;
Model 3: adjustment for age at visit 4, gender, race, study center, obesity, diabetes, smoking 
status, hypertension medication use, and systolic BP at visit 4.
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